RxDoctor Payments Data

Swarnjit Singh, MD

Gastroenterology · Chandler, AZNPI 1134128069

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.7% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 31.5% of the total. That places this record below the midpoint for gastroenterology clinicians in AZ, where the typical reported total is $3,568.

$1,688in general payments, 2019–2025

Across 80 payments — averaging $21.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$532
  • Gilead$275
  • Bristol Myers Squibb$250
  • Johnson & Johnson$182
  • Pfizer$120
  • Sanofi$77
  • plus $253 from 9 others

What the payments were for

  • Food & beverage$1,58294%
  • Education$1066%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,688 in reported general payments places this provider in the 35th percentile of 355 gastroenterology providers in Arizona.

See all gastroenterology providers in Arizona →

Medicare billing

Part B allowed, 2024
$66,684
Medicare patients
237
Services billed
490

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pantoprazole Sodium389$4,252
Dicyclomine Hcl89$2,944
Balsalazide Disodium12$1,446
Omeprazole38$614
Lactulose15$349
Famotidine20$322
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl13$187
Metoclopramide Hcl12$145
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine14$129

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Chandler

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →